Mahindra Manulife Mid Cap Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 30-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to seek to generate long term capital appreciation &provide long-term growth opportunities by investing in a portfolio constituted of equity & equityrelated securities and derivatives predominantly in mid cap companies. However, there can be noassurance that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Mahindra Manulife Mid Cap Fund - Direct Plan -Growth -0.59 -1.45 10.50 26.58 25.10 18.06
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Midcap 150 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mahindra Manulife Mid Cap Fund - Direct Plan -Growth Jan 30, 2018 10.50 26.58 25.10 0.45 4,294.84
HDFC Mid Cap Fund -Direct Plan - Growth Option Jan 01, 2013 14.45 26.90 26.08 0.71 92,641.55
Kotak Midcap Fund - Growth - Direct Jan 01, 2013 10.25 22.71 22.79 0.37 60,636.84
Nippon India Growth Mid Cap Fund - Direct Plan Growth Plan - Growth Jan 01, 2013 12.51 26.43 25.05 0.74 42,124.50
Motilal Oswal Midcap Fund-Direct Plan-Growth Option Feb 24, 2014 -1.74 24.17 27.16 0.74 36,880.18
Axis Midcap Fund - Direct Plan - Growth Jan 01, 2013 Unrated 8.21 20.57 18.91 0.55 31,717.15

Fund Holdings as on 31-December-2025

  • Glenmark Pharmaceuticals Limited

  • Indian Bank

  • Max Financial Services Limited

  • The Federal Bank Limited

  • IDFC First Bank Limited

  • Piramal Finance Limited

  • AIA Engineering Limited

  • UNO Minda Limited

  • IndusInd Bank Limited

  • APL Apollo Tubes Limited

  • Union Bank of India

  • JK Cement Limited

  • Blue Star Limited

  • Nippon Life India Asset Management Limited

  • KEI Industries Limited

  • Astral Limited

  • Indus Towers Limited

  • MphasiS Limited

  • Bharat Heavy Electricals Limited

  • Tube Investments Of India Limited

  • Marico Limited

  • Bharti Hexacom Limited

  • JSW Energy Limited

  • L&T Finance Limited

  • Anthem Biosciences Limited

  • Coforge Limited

  • Alkem Laboratories Limited

  • NMDC Limited

  • Aditya Birla Capital Limited

  • Godrej Properties Limited

  • Shriram Finance Limited

  • SRF Limited

  • Triveni Turbine Limited

  • Varun Beverages Ltd

  • Hexaware Technologies Limited

  • ITC Hotels Limited

  • Lupin Limited

  • Aster DM Healthcare Limited

  • Oil India Limited

  • Biocon Limited

  • Persistent Systems Ltd

  • Belrise Industries Ltd.

  • Fortis Healthcare Limited

  • Schaeffler India Limited

  • Equitas Small Finance Bank Limited

  • Solar Industries India Limited

  • Radico Khaitan Limited

  • LIC Housing Finance Limited

  • Minda Corporation Limited

  • Kajaria Ceramics Limited

  • Kirloskar Brothers Limited

  • Suzlon Energy Limited

  • Torrent Power Limited

  • Dalmia Bharat Limited

  • CEAT Limited

  • Mahindra Manulife Liquid Fund -Direct Plan -Growth

  • Page Industries Limited

  • LG Electronics India Ltd

  • Triparty Repo

  • JSW Infrastructure Ltd

  • PNB Housing Finance Limited

  • Atul Limited

  • Sri Lotus Developers and Realty Ltd.

  • Havells India Limited

  • Whirlpool of India Limited

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Bank - Private

  • Auto Ancillary

  • IT - Software

  • Bank - Public

  • Finance - NBFC

  • Finance - Housing

  • Telecommunication - Service Provider

  • Engineering - Industrial Equipments

  • Chemicals

  • Cement & Construction Materials

  • Power Generation/Distribution

  • Finance - Others

  • Castings/Forgings

  • Hospital & Healthcare Services

  • Construction - Real Estate

  • Steel & Iron Products

  • Air Conditioners

  • Finance - Asset Management

  • Cable

  • Plastic Products

  • Edible Oil

  • Electric Equipment

  • Mining & Minerals

  • Consumer Durables - Domestic Appliances

  • Consumer Food

  • Hotel, Resort & Restaurants

  • Oil Exploration

  • Bearings

  • Breweries & Distilleries

  • Ceramics/Marble/Granite/Sanitaryware

  • Compressors / Pumps

  • Tyres & Allied

  • Miscellaneous

  • Textile

  • Port

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About Mahindra Manulife Mid Cap Fund

Scheme Analysis

Mahindra Manulife Mid Cap Fund is a Equity - Mid Cap Fund fund and belongs to Mahindra Manulife Mutual Fund. It was launched on 30-Jan-2018 and currently has an AUM of ₹4,294.84 crore. Mahindra Manulife Mid Cap Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Midcap 150 - TRI as secondary index.

The NAV of Mahindra Manulife Mid Cap Fund ended up ₹0.24(0.64%)yesterday to ₹37.7816.

Among its top 3 holdings the fund has exposure to Glenmark Pharmaceuticals Limited, and

The Mahindra Manulife Mid Cap Fund is managed by Krishna Sanghavi and Manish Lodha.

Fund House Contact

Unit No. 204, 2nd Floor, Amiti Building Piramal Agastya Corporate Park, LBS Road, Kamani Junction, Kurla (W) Mumbai - 400070

022-66327900